Article
The usefulness of CD4/CD8 ratio evaluation in monitoring of ovarian cancer patients.
European journal of gynaecological oncology - 1 Jan 1995
Markowska J, Lacki J K, Jaroszewski J, Wiktorowicz K
Abstract excerpt
Twenty-seven ovarian cancer patients were observed for twenty-four months. The patients were grouped as follows: Group I-with complete (CR) or partial remission (PR), Group II-with stable disease (SD), Group III-with progression (PD) of the disease. In all patients, T lymphocyte phenotypes were estimated in peritoneal fluid (PF) and in peripheral blood (PB). No differences were observed in either PF and PBT...
Topics
- Adenocarcinoma
- Adult
- Aged
- Aged, 80 and over
- Ascitic Fluid
- CD4-CD8 Ratio
- Disease Progression
- Female
- Humans
- Leukocytes, Mononuclear
- Middle Aged
- Ovarian Neoplasms
